ArticleReviews in cardiovascular medicine2024
Cardiovascular Diseases Increased among the Rural and Urban Population of the Northern Regions of the Republic of Kazakhstan during COVID-19: A Descriptive Study with Forecasting.
Article in Reviews in cardiovascular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Cardiovascular Disease Burden in Rural Central Asia: A Systematic Review of Epidemiological Trends and Mortality Patterns.Epidemiologia (Basel, Switzerland) · 2026Review
- Patterns and determinants of premature mortality from non-communicable diseases in Aktobe region, Kazakhstan: a mixed-methods study.Frontiers in public health · 2026Article
- Prevalence and risk factors of cardiovascular diseases among youths in Kazakhstan: a systematic review of the literature.Future science OA · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The biggest health problem in most developed countries of the world, including Kazakhstan, is high morbidity and death rates due to cardiovascular diseases (CVD), both in urban and rural areas. As is known during the outbreak of COVID-19, the inaccessibility of many medical services played a big role in the incidence of CVD, in particular in the northern regions of the Republic of Kazakhstan (KZ). The objective of our research was to analyze the prevalence of CVD in city and village regions of the northern regions of the Republic of Kazakhstan, considering the outbreak period with forecasting. Methods: A descriptive study with forecasting was conducted based on the "Health of the population of the Republic of Kazakhstan and the activities of healthcare organizations", secondary statistical reporting data (collected volume) of the KZ. Information from this database was collected for five districts, two cities and one city of regional significance in the northern region of the KZ. Results: According to our descriptive study, the incidence of CVD indicates a comparatively large prevalence of CVD among the municipal population of the northern regions of the KZ. The prevalence of CVD in urban areas of the North Kazakhstan region (NKR) was 1682.02 (2015) and 4784.08 (2020) per 100,000 population. Among rural NKR residents, it was (per 100,000 population) 170.84 (2015) and 341.98 (2020). According to the forecast, by 2025, the incidence of CVD will grow, both in urban (7382.91/100,000) and in rural areas (417.29/100,000). Conclusions: Given the situation during the pandemic, the incidence of CVD has had a sharp increase, both in the rural and in urban areas of the northern regions of the KZ. This may be due to the poor availability of medical facilities, and medical services, which may have prevented timely diagnosis, as well as the psychology of the situation and the load on cardiac activity in relation to the pandemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.